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Summary Paget’s disease of bone (PDB) is a non-
inflammatory, metabolic, skeletal disorder charac-
terized by localized excessive osteoclastic bone re-
sorption that is followed by compensatory increased
osteoblastic activity leading to unstructured, fibrob-
lastic, and biomechanically unstable bone. As a result,
there is deformity and enlargement of the bone with
a defective and disorganized pattern. Here, we review
the epidemiology, etiology, pathology, macrostruc-
ture, histology, and quantitative histomorphometry
findings of PDB. Hyperosteoclastosis and poor defini-
tion of the boundary between cortical and medullary
bone are the main histological findings in PDB. Addi-
tionally, Pagetic bone is also characterized by hyper-
trophy and alteration of trabecular parameters.
Keywords Pagetic bone · Bone structure · Histology ·
Histomorphometry · Skeletal disorder
Epidemiologie und Pathologie des Morbus Paget
– ein Überblick
Zusammenfassung Der Morbus Paget ist eine nicht-
entzündliche metabolische Knochenerkrankung, die
durch eine lokale, übermäßige Knochenresorption
mit kompensatorischer Steigerung der Osteoblas-
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tenaktivität gekennzeichnet ist. In Folge kommt es
zu einem veränderten, fibrösen und biomechanisch
instabilen Knochen sowie zu Deformierungen und
Verdickungen des Knochens mit einer gestörten und
desorganisierten Struktur. In diesem Beitrag geben
wir eine Übersicht über die Epidemiologie, Ätiologie,
Pathologie, Makrostruktur, Histologie und die quan-
titative Histomorphometrie des Morbus Paget. Das
Auftreten von Riesenosteoklasten und die schlech-
te Abgrenzbarkeit von kortikalem und trabekulärem
Knochen sind wichtige histologische Kennzeichen
der Erkrankung. Darüber hinaus ist der Knochen bei
Morbus Paget auch durch eine Hypertrophie und
Veränderungen der Trabekelstruktur gekennzeichnet.
Schlüsselwörter Morbus Paget · Knochenstruktur ·
Histologie · Histomorphometrie · Knochenerkrankung
Introduction
Paget’s disease of bone (PDB) was originally described
in a report that has become a classic in the medical
literature. James Paget called the disease osteitis defor-
mans, in part because of the extensive and deforming
changes that took place in the skeleton in severe cases
[1]. The disease is a chronic bone abnormality, which
may affect a single, several, or many bones, but never
involves the entire skeleton. The cause remains un-
known. Nevertheless, a prevalent hypothesis is that
the disease is initiated by a slow virus in a genetically
vulnerable patient [2], because nuclear inclusions of
viral components have been observed in osteoclasts
from affected patients [3].
Paget’s disease of bone is the paradigm of a focal
bone disorder with accelerated bone turnover [4]. It is
a noninflammatory, metabolic, skeletal disorder char-
acterized by localized excessive osteoclastic bone re-
sorption that is followed by compensatory increased
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Fig. 1 Pagetic human femur, unknowngender andage, com-
paredtothehealthyfemurofthesameindividual. aAnteriorview,
bposterior view. Theboneswereobtained from thePathologic-
AnatomicalCollection inTheFoolsTower,MuseumofNatural
History, Vienna, Austria
osteoblastic activity [5] leading to unstructured, fi-
broblastic, and biomechanically unstable bone [6]. As
a result, there is deformity and enlargement of the
bone with a defective and disorganized pattern (plex-
iform bone) (Fig. 1 and 2); therefore, Pagetic bone is
susceptible to fractures [4]. The axial skeleton is fre-
quently involved and the bones most commonly af-
fected include the pelvis (70%), femur (55%), lumbar
spine (53%), skull (42%), and tibia (32%) [7, 8]. Nev-
ertheless, Pagetic bone lesions can occur at any site of
the skeleton [6].
Epidemiology
The diagnosis of PDB is rare before age 50. The disease
affects both men and women [9]; in most series males
predominate. In 1932, Schmorl [10] found a preva-
lence of 3% of PDB in a series of over 4600 autopsies
of individuals above 40 years of age.
Its geographical distribution is uneven, with areas
of high prevalence with familial aggregation detected
in most series [4]. Paget’s disease occurs most com-
monly in people of British descent. The disease is
also common in Britishmigrants to countries like Aus-
tralia, New Zealand, and North America, as well as
in other countries in Europe, such as in France, Ger-
many, Spain, or Italy [11]. Spain is considered to have
a medium–low prevalence compared to other Euro-
pean countries, approximately 0.9–1.3% of the pop-
ulation over 65 years [12]. The study by Poór et al.
[13] described the frequency of the disorder in eight
European cities, showing the lowest prevalence rate
among hospital patients ≥55 years old in the Austrian
city of Innsbruck (0.2%).
A study by Van Staa et al. [14] evaluated the age-
and gender-specific incidence of PDB in England and
Fig. 2 Lateral viewof aPagetic human femur, unknowngen-
der andage. Thebonewasobtained from thePathologic-
AnatomicalCollection inTheFoolsTower,MuseumofNatural
History, Vienna, Austria
Wales in the adult population. They concluded that
the disorder was more frequent among men of all
ages over 55 years. The incidence increased steeply
with age among both men and women, and was es-
timated at 0.3 cases per 10,000 person-years among
women aged 55–59 years and 0.5 cases per 10,000 per-
son-years among men of similar age. At the age of
≥85 years, this rate rose to 5.4 among women and
7.6 among men. Based on these assumptions, the
prevalence of clinically diagnosed PDB is 0.3% among
men and women ≥55 years old.
There is evidence that PDB has become less com-
mon and less severe over the past quarter of a century
in the UK and many other countries [13]. The de-
crease in the incidence of canine distemper ormeasles
virus infection due to the introduction of vaccination
in Europe may be associated with the decline of PDB
[13]. Previous studies described PDB, after osteoporo-
sis, as the second most common metabolic bone dis-
ease [10, 15].
Etiology
Studies of patients with Paget’s disease indicate that
there is a family history of the disorder in 5 [16] to
40% [17]. There is an autosomal dominant transmis-
sion pattern [9]. Mutations in the gene-producing se-
questosome 1 increase susceptibility to the develop-
ment of Paget’s disease [18], but there is incomplete
penetrance of the disease in some family members
who have been found to harbor gene mutations [19].
Other genes have also been implicated in increasing
susceptibility to develop the disorder [20], and nearly
all of these genes, including the sequestosome 1 gene,
are involved in osteoclast biology.
An additional role for sequestosome 1 is in au-
tophagy. Sequestosome 1 has been shown to inter-
act with an autophagic protein. Because of the pres-
ence of inclusion bodies found in the osteoclasts of
Pagetic bones, dysregulation of the autophagy pro-
cess may be part of the pathogenesis of PDB [21]. Re-
cently, the study by McManus et al. [22] indicated
a strong potential regulatory role for the kinase asso-
ciated with the response to the receptor activator of
NF-κB ligand (RANKL) activation in osteoclast stimu-
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latory pathways and autophagy induction, which may
contribute to the osteoclast phenotype in PDB.
Other investigations of the etiology of Paget’s dis-
ease have focused on the potential role of chronic
paramyxovirus infections contributing to the patho-
genesis of the disorder [23]. The most impressive an-
imal model of Paget’s disease has been generated in
transgenic mice by targeting the measles virus nucle-
ocapsid protein and a mutated sequestosome 1 gene
into the animals [24]. Immunocytochemical studies
have shown that Pagetic osteoclasts contain paramyx-
oviral-like nuclear inclusions that cross-react with an-
tibodies to measles virus, respiratory syncytial virus,
and canine distemper virus nucleocapsid antigen [23,
25, 26]. Nevertheless, the issue of whether or not viral
infections are related to PDB is not resolved [27].
Although the primary cause of these abnormalities
in Paget’s osteoclasts is still unknown [28], osteo-
clasts are abundant in Paget’s lesions. They are also
larger, contain increased nuclei per osteoclast, have
increased bone resorbing capacity, increased 1,25-
dihydroxyvitamin D3 (1,25-(OH)2D3) and RANKL re-
sponsivity, and secrete high levels of interleukin 6
(IL-6) compared to normal osteoclasts [29, 30]. The
increase in osteoclast numbers can be explained in
part by the high levels of expression of several factors
in Paget’s osteoclasts which are directly related to
osteoclast formation and activation, such as the c-fos
protooncogene [31], IL-6, IL-6 receptor, and NF-κB
[29]. In addition, Paget’s osteoclasts seem to respond
differently to osteotropic factors such as calcitonin
and 1,25-(OH)2D3 [32]. Pagetic osteoclasts frequently
express the measles virus nucleocapsid protein [33],
which induces high levels of IL-6 expression in both
human and mouse osteoclasts, and results in the
development of Pagetic bone lesions in mice in vivo
[34].
The Pagetic bone lesion
Macrostructure
Most patients are asymptomatic [4], whereas some de-
velop complications such as bone pain, osteoarthritis,
fracture, deformity, deafness, and nerve compression
syndromes [6]. The early lesions are predominantly
lytic and osteoporotic; bone resorption predominates
with abnormally large osteoclasts containing multi-
ple pleomorphic nuclei and microfilamentous inclu-
sion bodies [35]. Later, a mixed osteolytic-osteoblastic
phase with an abundance of osteoblasts forming new
matrix in the form of woven bone [36] occurs, where
thickening of the cortex by endosteal and periosteal
bone deposition with enlargement of the bones is ob-
served (Fig. 3). The trabecular architecture becomes
accentuated and its usually smooth outline assumes
irregular surface contours in radiographs [1]. Within
the diaphyseal cortex, the primary resorption phase
of PDB is often limited either to the endosteum or to
Fig. 3 Inside viewof aPagetic human femur, female, 71years
old. Thebonewasobtained from thePathologic-Anatomical
Collection inTheFoolsTower,MuseumofNaturalHistory, Vi-
enna, Austria
the central layers of the cortex. This results in pri-
mary resorption fronts that are usually discrete, both
radiologically and scintigraphically. The subsequent
activation of the subperiosteal cortex may be delayed,
leading to secondary expanding fronts associated with
subperiosteal new bone formation [37]. This alterna-
tion of resorptive and sclerotic areas creates a mottled
appearance on X-ray films.
Histology
A general description of histological findings in
Pagetic bones is summarized in Table 1. Most of
the studies on the histology of PDB have focused on
iliac crest bone [6, 36, 38–40] or on vertebrae [41, 42].
As mentioned before, PDB has the primary cellular
abnormality residing in osteoclasts [43], which are in-
creased in number and size, and contain many more
nuclei per cell compared to normal osteoclasts [44].
The histological study by Seitz et al. [6], using the
Hamburger Bone Register, described that trabecular
bone appeared mostly isolated, with a clumsy compo-
sition in Pagetic iliac crests biopsies. Multinucleated
osteoclasts with more than 12 nuclei per cell were
frequently detected at the trabecular bone surface.
Moreover, the authors observed a typical appearance
of deep resorption lacunae with the so-called swallow-
tail pattern. As a sign of accelerated bone formation,
they also found an increase in osteoid surfaces and
activated cuboidal osteoblasts, and described that
collagen fibers were not oriented in one direction, but
rather displayed a random distribution indicative of
woven bone [6].
Quantitative histomorphometry findings
Analyses of bone structure in Paget’s disease on
a quantitative (histomorphometric) level are surpris-
ingly rare. A histomorphometric study carried out in
two medieval preparations with PDB found evidence
of an increased trabecular thickness [45]. Histomor-
phometric results from Seitz et al. [6] showed a high
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Table 1 Descriptionof histological findings inPagetic bones





Number, size, and nuclearity:10-times
the number of osteoclasts; large: over




Increase [6, 11, 36,
42, 60]
Rate of bone resorption
Erosion rate of bone
Increase [36]
Nuclear inclusions Presence [61, 62]
Resorption surfaces Extend irregularly in multiple directions and
are unusually deep
Total resorption surfaces Increase [63]
Osteoclastic lacunae Irregular [60]
Osteoblasts and
deposition of bone
Chaotic fashion resulting in
woven bone in typical “mo-
saic” which is mechanically
weak
Poor definition of the boundary between
cortical and medullary bone
– – [11, 36,
64]
Hyperosteoblastosis associ-







Increase [6, 36, 42]
Alternating heavily calcified
and fibrotic areas
Isolated areas of poorly mineralized osteoid Fibrous tissue Increase [6, 36, 42,
64]





– Calcification rate (mineral
apposition rate)
Increase [36]
Hypervascularization – – Vascularity and marrow
fibrosis
Increase [11, 36]
bone turnover with a significant increase in bone
resorption and bone formation indices (trabecular
number, osteoid volume and osteoid surface, os-
teoblast number and surface of osteoclasts), and an
increased bone volume. However, Lauffenburger et al.
[38] stated that in PDB, there is a better correlation
between bone formation and bone resorption than in
osteoporosis. On the other hand, Cherian et al. [41]
observed that bone density was increased in vertebrae
affected by PDB, and the contribution from cortical
and trabecular bone was in the ratio expected in
normal bone. Cortical quantitative computed tomog-
raphy values were underestimated in PDB compared
with physical measurements of density. Furthermore,
in the histomorphometric analysis of Petska et al. [42],
affected vertebral body biopsies revealed a significant
increase both in trabecular bone volume as well as
in osteoid parameters. In comparison to histomor-
phometric data obtained from extraspinal skeletal
locations affected by PDB (i. e., iliac crest), a sim-
ilar bone microarchitecture of the vertebral bodies
was observed. They concluded that vertebral body
height and the spine bone volume together with bone
density might play an important role in the manifes-
tation of Pagetic bone alterations [42]. There is also
a histopathology study based on temporal bone [46],
in which authors only studied eight subjects; never-
theless, no quantitative results were shown. A general
description of structural findings in Pagetic bones is
summarized in Table 2.
An understanding of the normal skeletal distribu-
tion and the architecture of cancellous bone seems to
be essential for further knowledge of both the role of
bone cellular activity and also the diagnostic interpre-
tation of bone volume measurements [47]. There are
striking differences between peripheral and axial mea-
surement sites, and even between local areas of both.
For instance, in normal subjects, trabecular bone vol-
ume at the femoral neck is higher than at the lumbar
spine or the iliac crest. Of note, there is a systematic
variation in trabecular microarchitecture of the iliac
crest, showing the highest bone mass within the an-
terior part and lower values for the medial and dorsal
parts [47].
The functional attribution is most remarkable for
peripheral cancellous bone, such as in the metaphysis
of the long bones [48]. Thus, the relationship between
the trabecular bone mass at different skeletal sites has
been the subject of several previous studies [49–52].
Although these studies helped to gain an insight into
bone mass, bone structure, and bone diminution at
different sites under different diseases, their results
were conflicting [53–56]. An improvement of knowl-
edge about pathological skeletal conditions will de-
pend on a better understanding of the physiological
distribution of trabecular bone throughout the skele-
ton [47]. Considering the fact that the structure of tra-
becular bone is complex and that considerable skele-
tal heterogeneity exists [50], studies of Pagetic bone
structure in different regions of the skeleton are of
major interest.
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Table 2 Descriptionof structural findings inPagetic bones
Category Description/comment Parameters Direction References
Bone architecture and lamellar
texture
Small patches, scalloped contours and interlocked
by polycyclic cement lines: “structure of a puzzle”
Periosteocytic lacunae size in
the woven zones
Increase [36]
Trabecular microarchitecture Trabeculae are thick and numerous Trabecular bone volume
Trabecular number
Increase Iliac crest [6]
Spine [42]
Density of the bone tissue Increase [60]
Trabecular separation Decrease Iliac crest [6]
Spine [42]
Trabecular thickness Not altered Iliac crest [6]
Spine [42]
Hypertrophy of the bones Thickening and elongation of the bones – – [36, 60]
Non-mineralized bone (osteoid) – Osteoid volume
Osteoid surface
Osteoblast surface relative to
the osteoid surface
Increase Iliac crest [6]
Spine [42]
Nevertheless, there are no histomorphometric
studies based on long bones, only a case report [57]
of a femur fracture associated with PDB in an Asian
patient. Long bones are commonly affected by Paget’s
disease (55% femur and 32% tibia) [58], thus it is
crucial to get pertinent information about the basis of
skeletal complications including bowing deformities,
fractures of the Pagetic bone, and osteosarcoma [58].
In addition to long bones, Paget’s disease affect-
ing the skull is of particular clinical importance due
to its proximity to the nervous system. Neurologic
syndromes associated with Paget’s disease include
headache, dementia, brainstem and cerebellar dys-
function, cranial neuropathies, myelopathy, cauda
equina syndrome, and radiculopathies [59].
Future research directions
Since several studies of Pagetic bone structure in
different regions of the skeleton reveal similar find-
ings, we put forward the hypothesis that—despite
the phenomenon of skeletal heterogeneity—in PDB,
bone microarchitecture is altered independent of
the anatomic localization of the lesion in a uniform
manner. Identification of microstructure of Pagetic
bones and analyses of histological samples not only
helps to clarify the pathogenesis of PDB, but may also
contribute to a better knowledge about the physio-
logical distribution of cortical and trabecular bone
throughout the skeleton.
The scientific community needs further research
on bone microarchitecture, skeletal distribution, and
histological and histomorphometric characteristics in
bone samples with Paget’s disease.
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